PDCD1 and non-small cell lung carcinoma: Miedem et al. investigated a Zirconium-89 labeled anti-LAG-3 antibody, 89Zr-BI754111, in 2 patients with HNSCC and 4 patients with NSCLC who had already been treated with PD-1 or PD-L1 therapies.